Antiviral activity of a derivative of the photosensitive compound hypericin

Phytomedicine

Volumn 3, Issue 2, 1996, Pages 185-190

  Yip, L ^a   Hudson, J B ^a   Gruszecka Kowalik, E ^b   Zalkow, L H ^b   Towers, G H Neil ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Antiviral activity; Hypericin derivative; Photosensitizers

Indexed keywords

CYTOMEGALOVIRUS; MIRIDAE; MOUSE CYTOMEGALOVIRUS 1; MURINAE; POLIOVIRUS; SINDBIS VIRUS;

EID: 0000323869     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0944-7113(96)80034-1     Document Type: Article

References (26)

1. Andersen, D. O., Weber, N. D., Wood, S. G., Hughes, B. G., Murray, B. K., North, J. A.: In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antiviral Res. 16: 185-196, 1991.
2. Barnard, D. L., Huffman, J. H., Morris, J. L. B., Wood, S. G., Hughes, B. G., Sidwell, R. W.: Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. Antiviral Res. 17: 63-77, 1992.
3. Bonatti, S., Cancedda, R., Blobel, G.: Membrane biogenesis: in vitro cleavage, core glycosylation, and integration into microsomal membranes of Sindbis virus glycoproteins. J. Cell Biol. 80: 219-224, 1979.
4. Carpenter, S., Fehr, M. J., Kraus, G. A., Petrich, J. W: Chemiluminescent activation of the antiviral activity of hypericin: a molecular flashlight.Proc. Natl. Acad. Sci. USA 91: 12273-12277, 1994.
5. Carpenter, S., Kraus, G.: Photosensitization is required for inactivation of equine infectious anemia virus by hypericin. Photochem. Photobiol. 53 (2): 169-174, 1991.
6. Degar, S., Lavie, G., Meruelo, D.: Photodynamic inactivation of radiation leukemia virus produced from hypericin-treated cells. Virology 197: 796-800, 1993.
7. Degar, S., Prince, A. M., Pascual, D., Lavie, G., Levin, B., Mazur, Y., Lavie, D., Ehrlich, L. S., Carter, C., Meruelo, D.: Inactivation of the human immunodeficiency virus by hypericin: evidence for photochemical alterations of p 24 and a block in uncoating. AIDS Res. Hum. Retro. 8: 1929-1936, 1992.
8. Duran, N., Song, P. S.: Hypericin and its photodynamic action. Photochem. Photobiol. 43: 677-680. 1986.
9. Foote, C.: Type I and Type II mechanisms of photodynamic action. In: Heitz, J. R., Downum, K. R. (eds.): Light-Activated Pesticides, (ACS Symposium Series 339), Washington D. C. 1987, pp. 22-38.
10. Giese, A. C.: Hypericism. Photochem. Photobiol. Rev. 5: 229-255, 1980.
11. Gruszecka-Kowalik, E., Zalkow, L. H.: An improved synthesis of hypericin and related compounds. New derivatives of hypericin. 201st ACS National Meeting, Atlanta, GA., April 14-19. Book of Abstracts, Part I, MEDI 0037, 1991.
12. Hudson, J. B., Harris, L., Towers, G. H. N.: The importance of light in the anti-HIV effect of hypericin. Antiviral Res. 20: 173-178, 1993.
13. Hudson, J. B., Lopez-Bazzocchi, I., Towers, G. H. N.: Antiviral activities of hypericin. Antiviral Res. 15: 101-112, 1991.
14. Kraus, G. A., Pratt, D., Tossberg, J., Carpenter, S.: Antiretroviral activity of synthetic hypericin and related analogs. Biochem. Biophys. Res. Comm. 172: 149-153, 1990.
15. Kulig, M. J., Smith, L. L.: Sterol metabolism. XXV. Cholesterol oxidation by singlet molecular oxygen. J. Org. Chem. 38: 3639-3642, 1973.
16. Lavie, G., Mazur, Y., Lavie, D., Levin, B., Ittah, Y., Meruelo, D.: Hypericin as an antiretroviral agent: mode of action and related analogues. Ann. N. Y. Acad. Sci. 616: 556-562, 1990.
17. Lavie, G., Valentine, F., Levin, B., Mazur, Y., Gallo, G., Lavie, D., Meruelo, D.: Studies of the mechanism of action of the antiretroviral agents hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA 86: 5963-5967, 1989.
18. Lenard, J., Rabson, A., Vanderoef, R.: Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Proc. Natl. Acad. Sci. USA 90: 158-162, 1993.
19. Lenard, J.: Lipids of alphaviruses. In: Schlesinger, M. J. (ed.): Togaviruses: Biology, Structure and Replication. Academic Press, New York, 1980, pp. 335-341.
20. Lopez-Bazzacchi, I., Hudson, J. B., Towers, G. H. N.: Antiviral activity of the photoactive pigment hypericin. Photochem. Photobiol. 54: 95-98, 1991.
21. Meruelo, D., Degar, S., Levin, B., Lavie, D., Mazur, Y., Lavie, G.: Inactivation of retroviral particles of hypericin: Possible roles of oxidative reactions in the antiretroviral activity [abstract]. J. Acqu. Imm. D. 4 (3): 357-358, 1991.
22. Meruelo, D., Lavie, G., Lavie, D.: Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA 85: 5230-5234, 1988.
23. Moraleda, G., Wu, T. T., Jilbert, A. R., Aldrich, C. E., Condreay, D., Larsen, S. H., Tang, J. C., Colacino, J. M., Mason, W. S.: Inhibition of duck hepatitis B virus replication by hypericin. Antiviral Res. 20: 235-247, 1993.
24. Schinazi, R. F., Chu, C. K., Babu, J. R., Oswald, B. J., Saalmann, V., Cannon, D. L., Eriksson, B. F. H., Nasr, M.: Anthraquinones as a new class of antiviral agents against human immunodeficiency virus. Antiviral Res. 13: 265-272, 1990.
25. Tang, J., Colacino, J. M., Larsen, S. H., Spitzer, W.: Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses. Antiviral Res. 13: 313-326, 1990.
26. Zembower, D. E.: The synthesis and structure-activity relationships of biologically active anthraquinones. Ph. D. thesis, Georgia Institute of Technology, Atlanta, 1990.